Title Manager Engineering

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to its customers across geographies. The business is organized into two segments: Specialty Pharmaceuticals and Generics & APIs. Jubilant Generics (JGL), a wholly-owned subsidiary of Jubilant Pharma, operates Research & Development units in Noida and Mysore, India. The company has two manufacturing facilities - one in Mysore, Karnataka, and another in Roorkee, Uttarakhand - engaged in the production of APIs and Dosage manufacturing. The Mysore manufacturing location, spread over 69 acres, is a USFDA approved site specializing in manufacturing APIs for Lifestyle driven Therapeutic Areas such as CVS and CNS. It is a market leader in four APIs and among the top three players for three other APIs in its portfolio. On the other hand, the Roorkee facility is a state-of-the-art site approved by multiple regulatory bodies including USFDA, Japan PMDA, UK MHRA, TGA, WHO, and Brazil ANVISA. This facility focuses on a B2B model for EU, Canada, and emerging markets. Both manufacturing units are supported by approximately 500 research and development professionals based at Noida and Mysore. The R&D team works on developing new products in API, Solid Dosage Formulations of Oral Solid, Sterile Injectable, Semi-Solids Ointments, Creams, and Liquids. Additionally, all BA/BE studies are conducted in-house at an 80-bed facility with approvals from various regulatory authorities. JGL's Regulatory Affairs & IPR professionals ensure a unique portfolio of patents and product filings in regulatory and non-regulatory markets. Jubilant Pharma's revenue has shown a constant increase, reaching INR 53,240 Million in the Financial Year 2018-19 compared to INR 39,950 Million in the Financial Year 2017-18. For more information about the organization, please visit www.jubilantpharma.com.,